Literature DB >> 8412332

Hypercalcemia in the blastic phase of chronic myeloid leukemia associated with elevated parathyroid hormone-related protein.

J F Seymour, V Grill, T J Martin, N Lee, F Firkin.   

Abstract

We describe a case of hypercalcemia without lytic bone lesions complicating myeloid blast crisis of chronic myeloid leukemia (CML). Serum levels of parathyroid hormone-related protein (PTHrP) were elevated during the initial hypercalcemic period and became undetectable during chemotherapy-induced chronic phase, only to become elevated again during subsequent recurrent blastic periods repeatedly associated with hypercalcemia. Previously reported cases of hypercalcemia complicating CML are reviewed. It is suggested that PTHrP was responsible for the hypercalcemia in this case and may be an important mediator of hypercalcemia in CML.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8412332

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  2 in total

1.  Use of imatinib mesylate for favorable control of hypercalcemia mediated by parathyroid hormone-related protein in a patient with chronic myelogenous leukemia at blast phase.

Authors:  Natsuki Miyoshi; Hideo Tanaka; Takuo Ito; Yuta Katayama; Hiromasa Niimi; Hideo Hyodo; Akiro Kimura
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

2.  Primary hyperparathyroidism in a case of chronic myelogenous leukemia.

Authors:  Nasim Valizadeh; Faramarz Herfehdoust; Neda Valizadeh; Sara Vossoghian
Journal:  Indian J Endocrinol Metab       Date:  2013-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.